版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
NephroticSyndromeDepartmentofPrdiatrics,TongjiHospitalNephroticSyndrome
DefinitionEtiologyPathologyPathophysiologyClinicalManifestationLaboratoryDataDiagnosisTherapyandPrognosis
Male4yearsand6monthsoldComplaintofedemaandoliguriaDefinition:NephroticCriteria
MassiveproteinuriaISKDC:>40mg/m2/hrCAN:>+++trice/2wor>50-100mg/kg/24hrMendoza:UrineProtein/Cr≥2.0Hypoalbuminemia:<30g/LHyperlipidemia:Cholesterol>5.72mmol/LEdemaDefinition:NephriticCriteriaHematuria:RBC++(>10/HP),trice/2wHypertension:>130/90mmHginchildrenover7y>120/80mmHgin3-6ychildren>110/70mmHgin<3ychildrenAzotemia:BUN>6.4mmol/L,Cr>133umol/LHypocomplementemia:C3<0.8/LSecondaryNS:DIAMONDInfection:APSGN,HBV,HIV,shuntnephropathy,refluxnephropathy,leprosy,syphilis,schistosomiasis,hydatiddiseaseDrug,Toxic,Allegy:mercury,snakevenom,vaccine,pellicillamine,Heroin,gold,NSAID,captopril,probenecid,volatilehydrocarbonsNeoplasma:Hodgkin’sdisease,carcinoma(renalcell,lung,neuroblastoma,breast,andetc)Autoimmuneorcollagen-vasculardiseases:SLE,Hashimoto’sthyroiditis,EMC,HSP,VasculitisGeneticDisease:Alportsyn.,Fabrysyn.,Nail-patellasyn.,Sicklecelldisease,Amyloidosis,CongenitalnephropathyMetabolicdisease:DiabetesmellitusOthers:Chronictransplantrejection,congenitalnephrosclerosisPathology
PrimaryNS:MinimalChangeNephropathy(MCN):80%
Mesangialproliferativeglomerulonephritis(MsPGN):10-12%Focalsegmentalglomerulosclerosis(FSGS):5%Others:MembranousNephropathy(MN)―mostcommoninadultsMembraneproliferativeglomerulonephritis(MPGN):2-5%Cresentglomerulonephritis:rare,Crescentglomeruli>50%SecondaryNS:dependentoncauses,APSGN,MN,FSGS,MsPGNorMPGN
MinimalChangeNephropathy(MCN)LittleornomicroscopicabnormalityAbsenceofimmunecomplexesEffacementofepithelialfootprocessOccasionallymesangialhypercellurity
MCN:normalinLMMCN:effacementofepithelialfootprocessinEMMesangialproliferativeglomerulonephritis(MsPGN)
MesangialproliferationandexpansionIgG,C3andsometimesIgA,IgMdepositsinmesangialstalkElectron-densedepositsinmesangialorparamesangialareasMsPGN:
MesangialproliferationandexpansionIgGandC3depositsinmesangialMesangialproliferativeglomerulonephritis(MsPGN)
MesangialproliferationandexpansionIgG,C3andsometimesIgA,IgMdepositsinmesangialstalkElectron-densedepositsinmesangialorparamesangialareasFocalsegmentalglomerulosclerosis(FSGS)FocalandsegmentalcapillarycollapseandmesangialsclerosisDepositsofIgMorC3intheglomeruliLossofvisceralepithelialcellpodocytes,duplicationofthebasalGBMlamina,separationofepithelialcellfromGBMMembranousNephropathy(MN)DiffuseGBMthickening,characteristicGBMspikesSubepithelialdepositofIgGandC3Membraneproliferativeglomerulonephritis(MPGN)MesangialproliferationandexpansionSubendothelialmesangialinterposition,tramtrackapperanceMesangialandsubendothelialdepositsofIgGandC3Pathophysiologyofnephroticsyndrome
MCN:InvolvementofimmunesystemNoIgorcomplementdepositAssociationbetweenallegyandidiopathicNSAbnormalitiesofhumuralandcellularimmunity:IgG↓,IgA↓,CD4/CD8↓RelapseofNStriggeredbyavarietyofminorinfectionsAutologousremissionaftermeaslesInductionofremissionbycorticosteroidsandakylatingagents
MCN:pathogenesisofproteinuriaLymphacyte→29kdpeptide→glomerularpolyanion↓→proteinuriaConA→lymphacytes→60-160kdGPF→proteinurialymphacytes→13-18kdSIRS→proteinuriaGPF:glomerularpermeabilityfactorSIRS:solubleimmuneresponsesuppressorMCN:pathogenesisofedemaFFNa↓,CH2O↓
Edema
Proteinuria
Nareabsorptionindistalrenaltubules
Naandwaterretention
Edema
Hypoalbuminemia
intravascularoncoticpressure↓(25mmHg→6-8mmHg)
Fluidextravasation
hypovolemia
ADHandaldosterone
Waterandsaltretension
Edema
MCN:pathogenesisofhypoalbuminemiaMCN:pathogenesisofhyperlipidemiaHypoalbuminemia→hypaticsynthesisoflipid↑→hyperlipidemiaClinicalManifestation
Simplenephrosis:2--7y,massiveedemainfaceandparaorbitalareas,ascites,pleuraleffusion,lossofappetite,nauseaandvomiting,inertiaandlethargyNephriticnephrosis:>7y,moderateedema,grosshematuria,hypertensionComplications:Complications(1)Infection:URI,peritonitis,cellulitisandetc
IgG
,IgA
,Complement
WBCfunction
LackofZnandothertraceelementsHypercoagulablestateandthrombosis
HigherconcentrationofⅤ,Ⅶ,Ⅷ,ⅩLowerlevelofanticoagulantsubstance:antithrombinⅢ,proteinS,proteinCOvervigorousdiuresisHigherbloodviscosity,increasedplateletaggregationRoleofcorticosteroidsComplications(2)Electrolyteimbalance:hyponatrimia,hypokalemia,hypercalcemiaSalt-depleteddietOvervigorousdiuresisExtrarenallossProtein-boundcalciumlossfromurineSteroidsinducedhypocalcemiaARF:pre-renalHypovolemicshockOthers:growthfailureLaboratoryData(1)ESR:simplenephrosis>100mm/h,nephriticnephrosis<100mmHgSerumpreoteinelectrophoresis:
2
,
,
insimplenephrosisbut
innephriticNephrosisImmunoglobulin:IgG
,IgA
,IgM
IgA>IgM,C3
nephriticnephrosisIgM>IgA,normalC3
simplenephrosisLaboratoryData(2)Renalfunction:usuallynormalUrineproteinpattern:simplenephrosis
albuminnephriticnephrosis
IgG,albuminandothersRatioofUIgG/Ualbuminsimplenephrosis
<1nephriticnephrosis
>1DiagnosisanddifferentialdiagnosisIdiopathicorsecondaryMCNornon-MCNimportanceofrenalbiopsyTreatmentofNSGeneralprincipleAnticoagulationCorticosteroidsImmunosuppressiveagentsChinesetraditionalmedicineGeneralprincipleLowsaltdiet(2g/d),appropriateproteinintake(2-3g/kg/d)AvoidinginfectionDiuresis:Thiazide–DHCT2mg/kg/dAntisterone2-4mg/kg/dDextran10-20ml/kgfollowedbyLasixat2mg/kgAnticoagulation
Dipyridamole:5mg/kg/dHeparin:0.5-1mg/kg/d×7-10dWarfarin:initialdose:2.5mgTid×3-5dSubsequentdose:2.5-10mg/dbasedonPTCorticosteroidsShortcourse:2mg/kg/d→pro(-)1.5mg/kg/qod×4w→notaper,Course<8w,Relapserate(1y)=81%Standardcourse:2mg/kg/d×4w→2mg/kg/qod×4w→taper,
Course<6m,Relapserate(1y)=61%Longcourse:2mg/kg/d×4-6w→2mg/kg/qod×4-6w→taper,
Course<9-12m,Relapserate(1y)=31%Steroidstreatmentresponse
highresponse:4w→proteinuria(-)response:8w→proteinuria(-)partialresponse:8w→proteinuria(+/++)steroiddependent:responsivebutrequirehighdoserelapse:proteinuria(-)→proteinuria(++orup)frequentrelapse:relapsetwice/6mortrice/1ySideeffectofsteroidsGrowthfailureHypertensionposteriorsublenticularcataractsOsteoporoticbonediseaseGastriculcer→hematesis
Immunosuppressiveagents(1)CTX:2-2.5mg/kg/d×8-12w,maxiumsingledose0.1,maxiumcumulative200-250mg/kgChlorambucil:0.2mg/kg/d×8-12w,maxiumsingledose6mg,maxiumcumulativedose12-16mg/kgCyclosp
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 康复护理质量
- 2026湖南长沙宁乡市实施“千引”计划公开引进高层次医疗卫生专业人才(医学生)53人考试参考试题及答案解析
- 2026年哈尔滨市第三十九中学校临聘教师招聘1人考试备考试题及答案解析
- 南昌市劳动保障事务代理中心招聘3名项目外包服务人员考试参考题库及答案解析
- 2026国网上海市电力公司高校毕业生招聘45人(第二批)考试备考试题及答案解析
- 2026福建中医药大学附属人民医院招聘高层次人才61人笔试备考试题及答案解析
- 2026北京市丰台中西医结合医院招聘考试参考试题及答案解析
- 2026福建泉州晋江西园街道官前幼儿园招聘2人笔试备考试题及答案解析
- 2026年哈尔滨市第三十中学校招聘临时聘用教师考试备考题库及答案解析
- 2026年甘肃省中心医院康复医学中心康复医学科辅助治疗师岗位招聘15人考试参考题库及答案解析
- 2025年医疗机构内部管理与服务规范
- 2026年教师资格证教育知识与能力题库含答案
- 2025阻塞性睡眠呼吸暂停成人患者管理指南(更新住院版)课件
- 2025年通信基站安全管理与应急处理规范
- 村务监督委员会培训课件
- GB/T 20417.2-2025塑料丙烯腈-丁二烯-苯乙烯(ABS)模塑和挤出材料第2部分:试样制备和性能测定
- 2025云南富民县国有企业高级经营管理人员选聘2人笔试历年参考题库附带答案详解
- 采购助理岗位考试题及解析
- 2026年湖南大众传媒职业技术学院单招职业适应性考试题库附答案详解
- 玻璃加工厂安全生产管理制度
- 6.1.2 有性生殖(教学设计)生物新教材人教版八年级下册
评论
0/150
提交评论